Update on outcome assessment in myositis

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort

(2017) Sarah L. Tansley et al.   JOURNAL OF AUTOIMMUNITY

Myositis non-inflammatory mechanisms: An up-dated review

(2017) Emilia Manole et al.   JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study

(2017) Jin Kyun Park et al.   JOURNAL OF RHEUMATOLOGY

Physical function and muscle strength in sporadic inclusion body myositis

(2017) Anders N. Jørgensen et al.   MUSCLE & NERVE

Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies

(2017) Damien Bachasson et al.   NEUROLOGY

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)

(2017) Rabheh Abdul-Aziz et al.   Pediatric Rheumatology

Imaging of Myopathies

(2017) Lukas Filli et al.   RADIOLOGIC CLINICS OF NORTH AMERICA

2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects

(2017) Lisa G Rider et al.   RHEUMATOLOGY

The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies

(2017) Jessica Day et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies

(2017) Michal Feldon et al.   ARTHRITIS CARE & RESEARCH

Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients

(2017) Jemima Albayda et al.   ARTHRITIS CARE & RESEARCH

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheu

(2017) Rohit Aggarwal et al.   Arthritis & Rheumatology

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology Inter

(2017) Lisa G. Rider et al.   Arthritis & Rheumatology

An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis

(2017) Zhen-guo Huang et al.   PLoS One

Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus

(2016) Ana Jéssica Pinto et al.   CLINICAL RHEUMATOLOGY

The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis

(2016) Liguo Yin et al.   CLINICAL RHEUMATOLOGY

The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes

(2016) L. G. Rider et al.   JOURNAL OF INTERNAL MEDICINE

Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis

(2016) Consuelo M. López De Padilla et al.   JOURNAL OF RHEUMATOLOGY

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

(2016) Nicolino Ruperto et al.   LANCET

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

(2016) Jasper M Morrow et al.   LANCET NEUROLOGY

Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis

(2016) Valerie Williams et al.   MUSCLE & NERVE

Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center

(2016) Simone Barsotti et al.   MUSCLE & NERVE

Modeling functional decline over time in sporadic inclusion body myositis

(2016) Lindsay N. Alfano et al.   MUSCLE & NERVE

Development of the sporadic inclusion body myositis physical functioning assessment

(2016) Carla DeMuro et al.   MUSCLE & NERVE

Normative reference values for strength and flexibility of 1,000 children and adults

(2016) Marnee J. McKay et al.   NEUROLOGY

Evaluation of dysphagia by novel real-time MRI

(2016) Arno Olthoff et al.   NEUROLOGY

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18–20 September 2015

(2016) Olivier Benveniste et al.   NEUROMUSCULAR DISORDERS

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab

(2016) Rohit Aggarwal et al.   RHEUMATOLOGY

Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients

(2016) Kanneboyina Nagaraju et al.   RHEUMATOLOGY

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab

(2016) Rohit Aggarwal et al.   RHEUMATOLOGY

Targeting protein homeostasis in sporadic inclusion body myositis

(2016) Mhoriam Ahmed et al.   Science Translational Medicine

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

(2016) Hugh de Lautour et al.   ARTHRITIS CARE & RESEARCH

Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle

(2016) Iago Pinal-Fernandez et al.   ARTHRITIS CARE & RESEARCH

Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review

(2016) Valérie Leclair et al.   PLoS One

Biologic predictors of clinical improvement in rituximab-treated refractory myositis

(2015) Ann M. Reed et al.   BMC MUSCULOSKELETAL DISORDERS

Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease

(2015) Jing Zou et al.   CLINICAL RHEUMATOLOGY

Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measures

(2015) Jeannette M Olazagasti et al.   Journal of Inflammation-London

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis

(2015) Z. Betteridge et al.   JOURNAL OF INTERNAL MEDICINE

Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis

(2015) N. Kobayashi et al.   JOURNAL OF RHEUMATOLOGY

Patients Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure -- Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12

(2015) M. Regardt et al.   JOURNAL OF RHEUMATOLOGY

Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors

(2015) Mariko Ishizuka et al.   Modern Rheumatology

Patient-reported outcomes in core domain sets for rheumatic diseases

(2015) Lilian H. D. van Tuyl et al.   Nature Reviews Rheumatology

Immunological Biomarkers in Dermatomyositis

(2015) Jeannette M. Olazagasti et al.   Current Rheumatology Reports

2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2015) Tuhina Neogi et al.   Arthritis & Rheumatology

Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated

(2015) Beverley Almeida et al.   Arthritis & Rheumatology

Patient-reported Outcomes and Adult Patients' Disease Experience in the Idiopathic Inflammatory Myopathies. Report from the OMERACT 11 Myositis Special Interest Group

(2014) H. Alexanderson et al.   JOURNAL OF RHEUMATOLOGY

Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials

(2014) Jean-Yves Hogrel et al.   NEUROMUSCULAR DISORDERS

Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage

(2014) Helga Sanner et al.   PLoS One

Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease

(2014) Takahisa Gono et al.   RHEUMATOLOGY

Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis

(2014) N. Kobayashi et al.   RHEUMATOLOGY

Anti-signal recognition particle autoantibody ELISA validation and clinical associations

(2014) Rohit Aggarwal et al.   RHEUMATOLOGY

Correlation of CXCL10, Tumor Necrosis Factor Receptor Type II, and Galectin 9 With Disease Activity in Juvenile Dermatomyositis

(2014) F. Bellutti Enders et al.   Arthritis & Rheumatology

Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up

(2013) Mei Zong et al.   ANNALS OF THE RHEUMATIC DISEASES

Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease

(2013) Hemlata Varsani et al.   ANNALS OF THE RHEUMATIC DISEASES

A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients

(2013) Brandon W Higgs et al.   ANNALS OF THE RHEUMATIC DISEASES

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Ankle dorsi- and plantar-flexion torques measured by dynamometry in healthy subjects from 5 to 80 years

(2013) Amélie Moraux et al.   BMC MUSCULOSKELETAL DISORDERS

BAFF Expression Correlates with Idiopathic Inflammatory Myopathy Disease Activity Measures and Autoantibodies

(2013) C. M. LOPEZ De PADILLA et al.   JOURNAL OF RHEUMATOLOGY

Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease

(2013) Mizuho Nara et al.   Modern Rheumatology

Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials

(2013) A. Cortese et al.   NEUROMUSCULAR DISORDERS

188th ENMC International Workshop: Inclusion Body Myositis, 2–4 December 2011, Naarden, The Netherlands

(2013) M.R. Rose   NEUROMUSCULAR DISORDERS

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis

(2013) L.N. Alfano et al.   NEUROMUSCULAR DISORDERS

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

(2013) Lesley Ann Saketkoo et al.   THORAX

Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis

(2013) Kiran Nistala et al.   ARTHRITIS RESEARCH & THERAPY

Immune-Mediated Necrotizing Myopathy Is Characterized by a Specific Th1-M1 Polarized Immune Profile

(2012) Corinna Preuße et al.   AMERICAN JOURNAL OF PATHOLOGY

MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis

(2012) C Malattia et al.   ANNALS OF THE RHEUMATIC DISEASES

The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis

(2012) Dragana Lazarevic et al.   ANNALS OF THE RHEUMATIC DISEASES

Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course

(2012) Ann M. Reed et al.   ARTHRITIS AND RHEUMATISM

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial

(2012) Chester V. Oddis et al.   ARTHRITIS AND RHEUMATISM

Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis

(2012) Yves Allenbach et al.   NEUROMUSCULAR DISORDERS

Prognosis and prognostic factors in sporadic inclusion body myositis

(2011) C. Lindberg et al.   ACTA NEUROLOGICA SCANDINAVICA

A randomized, pilot trial of etanercept in dermatomyositis

(2011)   ANNALS OF NEUROLOGY

Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO)

(2011) Nicolino Ruperto et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO study

(2011) Rachana Hasija et al.   ARTHRITIS AND RHEUMATISM

Long-term observational study of sporadic inclusion body myositis

(2011) O. Benveniste et al.   BRAIN

Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects

(2011) Thomas Harbo et al.   EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY

Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis

(2011) Linda Pax Lowes et al.   MUSCLE & NERVE

Rituximab treatment in patients with refractory inflammatory myopathies

(2011) E. A. M. Mahler et al.   RHEUMATOLOGY

Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis

(2011) F. M. Cox et al.   RHEUMATOLOGY

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ),

(2011) Lisa G. Rider et al.   ARTHRITIS CARE & RESEARCH

Consensus treatments for moderate juvenile dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference

(2011) Adam M. Huber et al.   ARTHRITIS CARE & RESEARCH

Risk Alleles for Systemic Lupus Erythematosus in a Large Case-Control Collection and Associations with Clinical Subphenotypes

(2011) Kimberly E. Taylor et al.   PLoS Genetics

Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells

(2010) Sheela Shrestha et al.   ARTHRITIS AND RHEUMATISM

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report

(2010) Tuhina Neogi et al.   ARTHRITIS AND RHEUMATISM

What determines quality of life in inclusion body myositis?

(2010) R. Sadjadi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

(2010) Lisa G. Rider et al.   ARTHRITIS CARE & RESEARCH

The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis

(2010) Nicolino Ruperto et al.   ARTHRITIS CARE & RESEARCH

Isokinetic and isometric muscle strength in a healthy population with special reference to age and gender

(2009) B. Danneskiold-Samsøe et al.   Acta Physiologica

Health-related quality of life of patients with juvenile dermatomyositis: Results from the paediatric rheumatology international trials organisation multinational quality of life cohort study

(2009) Maria Teresa Apaz et al.   ARTHRITIS AND RHEUMATISM

Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment

(2009) Susan Kim et al.   ARTHRITIS AND RHEUMATISM

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies

(2008) O Krystufkova et al.   ANNALS OF THE RHEUMATIC DISEASES

Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood

(2008) Brian M Feldman et al.   LANCET

Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity

(2008) C.E. Jackson et al.   MUSCLE & NERVE

Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis

(2008) M. O. Harris-Love et al.   RHEUMATOLOGY